The Medicines Company and Alnylam Pharmaceuticals Announce Initiation of Phase III Clinical Trials of Inclisiran
Go back to The Medicines Company and Alnylam Pharmaceuticals Announce Initiation of Phase III Clinical Trials of Inclisiran| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 288.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $288.18 | 52 Week High | $109.10 | |||
| Open | $288.18 | 52 Week Low | $31.38 | |||
| Day High | $288.18 | P/E | N/A | |||
| Day Low | $288.18 | EPS | $-1.45 | |||
| Volume | 46 | |||||
| Medicines Co (NASDAQ: MDCO) | Delayed: 84.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $84.90 | 52 Week High | $43.00 | |||
| Open | $3.15 | 52 Week Low | $27.50 | |||
| Day High | $84.90 | P/E | 339.60 | |||
| Day Low | $84.90 | EPS | $0.25 | |||
| Volume | 413,822 | |||||
